Private Capital Group’s Filana Therapeutics FLNA Stock Holding History

Private Capital Group’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9	Closed	–	–	2076
2022 Q1	$0	Hold	9	–	–	﹤0.01%	2189
2021 Q4	$0	Hold	9	–	–	﹤0.01%	2175
2021 Q3	$1K	Buy	+9	New	+$751	﹤0.01%	2048

Other funds holding FLNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Private Capital Group's FLNA Position: Q2 2022 in Review

Private Capital Group sold out of Filana Therapeutics (FLNA) in Q2 2022, closing a stake of 9 shares.

Private Capital Group first reported a position in FLNA in Q3 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 149 funds tracked by Wall St. Rank hold FLNA as of Q2 2022.

Private Capital Group reported no remaining Filana Therapeutics position as of Q2 2022 after selling out during the quarter.
Private Capital Group sold 9 Filana Therapeutics shares in Q2 2022.
Private Capital Group first reported a position in Filana Therapeutics in Q3 2021 and held it in 3 quarters.
Private Capital Group's Filana Therapeutics position peaked at $1K in Q3 2021.
149 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.